Biopiracy & Indigenous Plant Rights
Disputes over pharmaceutical companies' access to and commercialization of traditional plants and indigenous knowledge, with governments and communities seeking to protect sacred resources and ensure equitable benefit-sharing.
1 event tracked
Today in Biopiracy & Indigenous Plant Rights
Gabon is moving to protect iboga, a traditionally sacred plant, from commercial exploitation and patenting by US pharmaceutical firms, marking a significant assertion of indigenous plant rights against biopiracy concerns. The action highlights the ongoing tension between developing nations seeking to control their genetic resources and pharmaceutical companies interested in commercializing natural compounds for drug development. The dispute centers on intellectual property frameworks, access to genetic resources, and how benefits from natural product commercialization should be distributed between indigenous communities and commercial entities. Gabon's protective stance reflects broader global concerns about biopiracy, where foreign companies profit from plants with deep cultural and medicinal significance to local populations without adequate compensation or consent from source countries.